CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 37 filers reported holding CATALYST BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $140,000 | +169.2% | 78,622 | 0.0% | 0.06% | +346.2% |
| Q1 2022 | $52,000 | -27.8% | 78,622 | 0.0% | 0.01% | -18.8% |
| Q4 2021 | $72,000 | -77.7% | 78,622 | 0.0% | 0.02% | -77.8% |
| Q3 2021 | $323,000 | -5.0% | 78,622 | 0.0% | 0.07% | +44.0% |
| Q2 2021 | $340,000 | -14.1% | 78,622 | 0.0% | 0.05% | -19.4% |
| Q1 2021 | $396,000 | -20.2% | 78,622 | 0.0% | 0.06% | -51.9% |
| Q4 2020 | $496,000 | +46.7% | 78,622 | 0.0% | 0.13% | -28.3% |
| Q3 2020 | $338,000 | -26.8% | 78,622 | 0.0% | 0.18% | -20.7% |
| Q2 2020 | $462,000 | +34.3% | 78,622 | 0.0% | 0.23% | +2.7% |
| Q1 2020 | $344,000 | -35.7% | 78,622 | 0.0% | 0.22% | -11.6% |
| Q4 2019 | $535,000 | +38.6% | 78,622 | 0.0% | 0.25% | +4.2% |
| Q3 2019 | $386,000 | -33.3% | 78,622 | 0.0% | 0.24% | -28.1% |
| Q2 2019 | $579,000 | – | 78,622 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |